Mediastinal mass due to Aspergillus fumigatus after lung transplantation: A case report

Journal of Heart and Lung Transplantation

Volumn 24, Issue 11, 2005, Pages 1991-1994

  Shlobin, Oksana Anatolia ^a   Dropulic, Lesia K ^a   Orens, Jonathan B ^a   Mcdyer, John F ^a   Conte, John V ^a   Yang, Stephen Y ^a   Girgis, Reda ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; VORICONAZOLE; WARFARIN;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ACUTE KIDNEY FAILURE; ADULT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CASE REPORT; CREATININE BLOOD LEVEL; CYSTIC FIBROSIS; FEMALE; FEVER; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LEFT ATRIUM; HUMAN; LUNG TRANSPLANTATION; MEDIASTINUM MASS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RELAPSE; TREATMENT OUTCOME;

ADULT; AMPHOTERICIN B; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CYSTIC FIBROSIS; DRUG THERAPY, COMBINATION; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; LUNG TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MEDIASTINAL DISEASES; PEPTIDES, CYCLIC; POSTOPERATIVE COMPLICATIONS; PYRIMIDINES; RECURRENCE; THORACOSCOPY; TRIAZOLES;

EID: 27844569483     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2005.02.020     Document Type: Article

References (24)

1. C. Chaparro, J.R. Maurer, D. Chamberlain Causes of death in lung transplant recipients J Heart Lung Transplant 13 1994 758 763
2. R. Guillemain, V. Lavarde, C. Amrein, P. Chevalier, A. Guinvarc'h, D. Glotz Invasive aspergillosis after transplantation Transplant Proc 27 1995 1307 1309
3. B. Mehrad, G. Paciocco, F.J. Martinez, T.C. Ojo, M.D. Iannettoni, J.P. Lynch 3rd Spectrum of Aspergillus infection in lung transplant recipients Chest 119 2001 169 175
4. A. Minari, R. Husni, R.K. Avery The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants Transpl Infect Dis 4 2002 195 200
5. M. Ahmad, A.J. Weinstein, J.A. Hughes, D.E. Cosgrove Granulomatous mediastinitis due to Aspergillus flavus in a nonimmunosuppressed patient Am J Med 70 1981 887 890
6. W.J. Wells, A.H. Fox, P.R. Theodore, L.A. Ross, P. Stanley, V.A. Starnes Aspergillosis of the posterior mediastinum Ann Thor Surg 57 1994 1240 1243
7. D.A. Stevens, V.L. Kan, M.A. Judson Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America Clin Infect Dis 30 2000 696 709
8. M.R. Kramer, D.W. Denning, S.E. Marshall Ulcerative tracheobronchitis after lung transplantation A new form of invasive aspergillosis Am Rev Resp Dis 144 1991 552 556
9. N. Singh, D.L. Paterson Aspergillus infections in transplant recipients Clin Microbiol Rev 18 2005 44 69
10. N. Singh, S. Husain Aspergillus infections after lung transplantation clinical differences in type of transplant and implications for management J Heart Lung Transplant 22 2003 258 266
11. L.J. Paradowski Saprophytic fungal infections and lung transplant - revisited J Heart Lung Transplant 16 1997 524 531
12. D.R. Nunley, P. Ohori, W.F. Grgurich Pulmonary aspergillosis in cystic fibrosis lung transplant recipients Chest 114 1998 1321 1329
13. P.A. Flume, T.M. Egan, L.J. Paradowski, F.C. Detterbeck, J.T. Thompson, J.R. Yankaskas Infectious complications of lung transplantation impact of cystic fibrosis Am J Resp Crit Care Med 149 1994 1601 1607
14. M Helmi, R.B. Love, D. Welter, R.D. Cornwell, K.C. Meyer Aspergillus infection in lung transplant recipients with cystic fibrosis risk factors and outcomes comparison to other types of transplant recipients Chest 123 2003 800 808
15. V. Yeldandi, F. Laghi, M.A. McCabe Aspergillus and lung transplantation J Heart Lung Transplant 14 1995 883 890
16. B.C. Cahill, J.R. Hibbs, K. Savik Aspergillus Airway colonization and invasive disease after lung transplantation Chest 112 1997 1160 1164
17. R.N. Husni, S.M. Gordon, D.L. Longworth Cytomegalovirus infections is a risk factor for invasive aspergillosis in lung transplant recipients Clin Infect Dis 26 1998 753 755
18. M. Green, R.K. Avery, J. Preiksaitis Guidelines for the prevention and management of infectious complications of solid organ transplantation Am J Transplant 4 suppl 10 2004 110 134
19. H. Reichenspurner, P. Gamberg, M. Nitschke Significant reduction in the number of fungal infections after lung- heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis Transplant Proc 29 1997 627 628
20. R. Herbrecht, D.W. Denning, T.F. Patterson Voriconazole vs. amphotericin B for primary therapy of IA N Engl J Med 347 2002 408-1
21. M.D. Johnson, J.R. Perfect Caspofungin first approved agent in a new class of antifungals Expert Opin Pharmacother 4 2003 807 823
22. T.J. Walsh, H. Teppler, G.R. Donowitz Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia N Engl J Med 351 2004 1391 1402
23. S. Perea, G. Gonzalez, A.W. Fothergill, W.R. Kirkpatrick, M.G. Rinaldi, T.F. Patterson In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp Antimicrob Agents Chemother 46 2002 3039 3041
24. V. Petraitis, R. Petraitiene, A.A. Sarafandi Combination therapy in treatment of experimental pulmonary aspergillosis synergistic interaction between an antifungal and an echinocandin J Infect Dis 187 2003 1834 1843